News about Drug Discovery & Development

NIPER Raebareli and AstraZeneca India Boost Clinical Research

NIPER Raebareli and AstraZeneca India have partnered under Biopharma SHAKTI to strengthen clinical trial capabilities across 25 emerging geographies in India.

Drug Discovery & Development | 15/10/2026 | By News Bureau

Piramal Pharma Solutions Advances Cyclophosphamide Development

Piramal Pharma Solutions and NP2 plan to complete development of generic cyclophosphamide in October.

Drug Discovery & Development | 01/10/2026 | By News Bureau |  120

NIH Study Maps Molecular Drivers of Alzheimer's and Brain Disorders

NIH-supported PsychAD research mapped molecular drivers of Alzheimer’s and related brain disorders using a single-cell atlas of over 6.3 million nuclei from 1,494 donors.<br />

Drug Discovery & Development | 28/09/2026 | By News Bureau |  117

NIH-Funded Study Finds K-9 Reverses Vision Loss in MS Models

The NIH-funded study found that K-9 protected nerve fibres and helped reverse vision and motor impairment in animal models of multiple sclerosis.

Drug Discovery & Development | 25/09/2026 | By News Bureau |  123

ERS Genomics and Sai Life Sciences Sign CRISPR/Cas9 Deal

ERS Genomics and Sai Life Sciences Sign CRISPR/Cas9 License Deal for Precision Genome Editing in Drug Development.

Drug Discovery & Development | 23/09/2026 | By News Bureau |  135

Experts Call for Better Drug Delivery to Aging Brain

Multidisciplinary team, including a BITS Pilani researcher, calls for better drug delivery to the aging brain, noting entry is only the first step.

Drug Discovery & Development | 23/09/2026 | By News Bureau |  122

Johns Hopkins Researchers Develop Cloud-Based Microscope for Continuous Brain Monitoring

Johns Hopkins researchers have developed CloudScope, a cloud-based microscope that enables continuous remote monitoring of brain activity and disease-related changes in freely moving mice for more than 24 hours.

Drug Discovery & Development | 15/09/2026 | By News Bureau |  130

Johns Hopkins Researchers Identify Human Resistin as Key Driver of Inflammatory Pathway

Researchers found that blocking human resistin with a targeted antibody reduced activation of the NLRP3 inflammatory pathway, pointing to a potential target for future therapies.

Drug Discovery & Development | 07/09/2026 | By News Bureau |  142

New Study Reveals Temperature-Induced Structure Recovery Patterns for Drug Delivery

The Raman Research Institute (RRI) researchers study temperature-induced structure recovery in glass, exploring ways to erase material memory and potentially improve drug delivery systems.

Drug Discovery & Development | 02/09/2026 | By News Bureau |  111

New Molecular Method Speeds Drug Discovery by Swapping a Single Atom

Chicago chemists develop a faster and cheaper method to convert isoxazoles into pyrroles, potentially accelerating drug discovery and pharmaceutical development.

Drug Discovery & Development | 02/09/2026 | By News Bureau |  127